Home > Insider Trading > Filing (0001522767-23-000071)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1522767	Marimed Inc.	MRMD	Medicinal Chemicals & Botanical Products (2833)	274672745

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1866577	Timothy Shaw	C/O Marimed Inc. 10 Oceana Way Norwood, MA 02062	Chief Operating Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-04-27	111,111	$0.00	8,410,619	No	4	M	Direct
Common Stock	Disposition	2023-04-28	39,371	$0.37	8,371,248	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock, Par Value $.001 Per Share	Restricted Stock Units (RSU)	Disposition	2023-04-27	111,111	$0.00	111,111	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
555,556			No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,000,000	Indirect	By the Shaw Family Trust

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock, Par Value $.001 Per Share	Restricted Stock Units (RSU)	$0.00		130,000	130,000	Direct
Common Stock, Par Value $.001 Per Share	Option to buy common stock	$0.90	2026-10-01	1,250,000	1,250,000	Direct
Common Stock, Par Value $.001 Per Share	Option to buy common stock	$0.88	2026-07-09	1,250,000	1,250,000	Direct
Common Stock, Par Value $.001 Per Share	Option to buy common stock	$0.30	2025-03-31	50,000	50,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
	130,000	130,000	Direct
2026-10-01	1,250,000	1,250,000	Direct
2026-07-09	1,250,000	1,250,000	Direct
2025-03-31	50,000	50,000	Direct

Footnotes

RSUs convert to common stock on a one-for-one basis.
Reflects common stock sold pursuant to a rule 10b5-1 instruction letter previously adopted by the Reporting Person to satisfy tax withholding obligations in connection with RSUs.
The reporting person's spouse is the trustee of the trust and the shares held in the trust are for the benefit of the reporting person's children. The trust is an irrevocable trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
The RSUs vest over a three year period in equal one-sixth installments every six months following the October 27, 2022 grant date, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.
The RSUs vest over a three year period of which 43,333 RSUs will vest on March 7, 2024 and thereafter, 21,667 RSUs will vest every succeeding six (6) months through March 7, 2025, on each of September 7 and March 7, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.
Immediately